{
    "organizations": [],
    "uuid": "a01d9137372d1665734ff54f70392997fb22412d",
    "author": "",
    "url": "https://www.reuters.com/article/brief-galmed-pharmaceuticals-q1-loss-per/brief-galmed-pharmaceuticals-q1-loss-per-share-0-17-idUSASC0A0WU",
    "ord_in_thread": 0,
    "title": "BRIEF-Galmed Pharmaceuticals Q1 Loss Per Share $0.17",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 9, 2018 / 11:21 AM / in 11 minutes BRIEF-Galmed Pharmaceuticals Q1 Loss Per Share $0.17 Reuters Staff\nMay 9 (Reuters) - Galmed Pharmaceuticals Ltd:\n* GALMED PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS * Q1 LOSS PER SHARE $0.17\n* Q1 EARNINGS PER SHARE VIEW $-0.24 â€” THOMSON REUTERS I/B/E/S * Q1 REVENUE $300,000\n* REAFFIRMING SCHEDULE OF RELEASE OF ARREST STUDY TOP LINE RESULTS ",
    "published": "2018-05-09T14:19:00.000+03:00",
    "crawled": "2018-05-09T14:41:12.005+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "minute",
        "pharmaceutical",
        "q1",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "may",
        "reuters",
        "galmed",
        "pharmaceutical",
        "ltd",
        "galmed",
        "pharmaceutical",
        "provides",
        "business",
        "update",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "q1",
        "loss",
        "per",
        "share",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "q1",
        "revenue",
        "reaffirming",
        "schedule",
        "release",
        "arrest",
        "study",
        "top",
        "line",
        "result"
    ]
}